Literature DB >> 3054595

[Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study].

K H Grotemeyer1, H P Schlake, I W Husstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054595

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  7 in total

1.  [Not Available].

Authors:  K H Grotemeyer
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

2.  Systematic review of the pharmacological agents that have been tested against spreading depolarizations.

Authors:  Anna Klass; Renan Sánchez-Porras; Edgar Santos
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-20       Impact factor: 6.200

Review 3.  The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers.

Authors:  V Limmroth; M C Michel
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 4.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions.

Authors:  Fengpeng Li; Enchao Qiu; Zhao Dong; Ruozhuo Liu; Shiwen Wu; Shengyuan Yu
Journal:  J Headache Pain       Date:  2011-02-25       Impact factor: 7.277

6.  Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; Akira Kuriyama; Yachiyo Kuwatsuka; Sarah Nickoloff; Derek Storch; Wilkins Jackson; Zhi-Jiang Zhang; Yasuaki Hayashino
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

7.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.